Clinics and Research in Hepatology and Gastroenterology

Safety and effectiveness of GLP-1 receptor agonists and SGLT-2 inhibitors in liver transplant recipients with diabetes

By Alessandra Mazzola, Philippe Sultanik, Aida Rebiha, Filoména Conti

Cohort study of 41 peopleInterventions

11.0 months

The paper

Alessandra Mazzola, Philippe Sultanik, Aida Rebiha, Filoména Conti

Sorbonne Université

Clinics and Research in Hepatology and Gastroenterology, 6 Aug 2026

doi.org/10.1016/j.clinre.2026.102899 PubMed 42562072

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression